Intrinsic Value of S&P & Nasdaq Contact Us

Canopy Growth Corporation CGC NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.47
+1227.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Canopy Growth Corporation (CGC) has a negative trailing P/E of -1.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -67.03%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+1227.5%).
  • Trailing Earnings Yield -67.03% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $14.47 (+1227.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 38/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
38/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
37/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — CGC

Valuation Multiples
P/E (TTM)-1.5
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.64
P/S Ratio0.92
EV/EBITDA-0.6
Per Share Data
EPS (TTM)$-0.95
Book Value / Share$2.19
Revenue / Share$0.81
FCF / Share$-0.25
Yields & Fair Value
Earnings Yield-67.03%
Dividend Yield0.00%
Analyst Target$14.47 (+1227.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -572.7 6.75 16.17 157.65 -
2017 -763.4 -3.66 20.62 317.77 -
2018 -1,103.1 -9.08 51.53 766.09 -
2019 -285.6 -0.53 27.53 845.46 -
2020 -53.7 -0.54 20.67 177.94 -
2021 -86.5 -6.99 43.37 276.22 -
2022 -12.0 -0.16 1.03 7.80 -
2023 -0.3 0.00 1.45 3.29 -
2024 -1.6 0.02 2.07 3.48 -
2025 -0.2 0.02 0.29 0.52 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-0.05 $12.7M $-3.5M -27.5%
2016 $-0.14 $39.9M $-16.61M -41.6%
2017 $-0.31 $77.95M $-54.13M -69.4%
2018 $-1.99 $226.34M $-670.09M -296.1%
2019 $-39.86 $398.77M $-1.39B -347.9%
2020 $-44.96 $546.65M $-1.67B -305.6%
2021 $-8.19 $520.33M $-320.49M -61.6%
2022 $-71.37 $402.9M $-3.31B -821.4%
2023 $-8.79 $297.15M $-657.27M -221.2%
2024 $-5.53 $267.45M $-594.68M -222.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.33 $-0.35 – $-0.31 $205.74M $202.99M – $207.62M 3
2027 $-0.18 $-0.29 – $-0.06 $248.71M $232.42M – $265M 3
2028 $-0.15 $-0.16 – $-0.14 $262.63M $250.69M – $276.93M 1
2029 $-0.07 $-0.08 – $-0.07 $260.23M $248.4M – $274.4M 1
2030 $-0.03 $-0.03 – $-0.03 $277.11M $264.51M – $292.2M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message